Endometriosis is a chronic condition that ranges from a manageable nuisance to a disease that damages organs, causes debilitating pain, and significantly impairs fertility. It affects roughly 10% of women of reproductive age worldwide, about 190 million people. The seriousness varies enormously from person to person, and one of the most frustrating aspects of the disease is that clinical staging doesn’t reliably predict how bad someone’s symptoms will be.
Stage Doesn’t Always Match Severity
Doctors classify endometriosis into four stages using a point-based scoring system. Stage I (minimal) involves small, superficial implants. Stage II (mild) means slightly more tissue involvement. Stage III (moderate) includes deeper implants and possible cysts on the ovaries. Stage IV (severe) involves extensive deep implants, large ovarian cysts, and dense scar tissue binding organs together. A single finding of complete obliteration of the space behind the uterus automatically scores as severe disease.
Here’s the counterintuitive part: someone with Stage I can experience excruciating pain, while someone with Stage IV might have minimal symptoms and only discover the disease during a fertility workup. Research has found no consistent relationship between stage and the severity of period pain or chronic pelvic pain. The one exception is pain during sex, which does correlate with stage. Women reporting significant pain during intercourse are about five times more likely to have a higher stage of disease. This disconnect between what doctors see on imaging or in surgery and what patients actually feel is one reason the condition is so often dismissed or misdiagnosed.
The Diagnostic Delay Problem
One of the most serious aspects of endometriosis isn’t the biology itself but how long it takes to get a diagnosis. The average delay from symptom onset to diagnosis is roughly 7.5 to 10 years, depending on the country and the study. In the United Kingdom, the mean delay is currently estimated at nine years, and recent data suggests this gap may actually be widening rather than shrinking.
During those years, the disease can progress silently. Scar tissue builds up. Organs can become involved. Fertility may decline. Many women cycle through multiple doctors hearing that their pain is “normal periods” before anyone considers endometriosis. This delay is not just an inconvenience. It represents years of untreated disease and unnecessary suffering that can shape the long-term trajectory of someone’s health.
How It Affects Fertility
Between 30% and 50% of women with endometriosis are infertile, and 25% to 50% of women seeking help for infertility turn out to have the disease. Those numbers make endometriosis one of the leading causes of difficulty conceiving.
The reasons are multiple. Endometrial tissue growing outside the uterus triggers inflammation that can damage eggs and sperm, interfere with ovulation, and distort the anatomy of the fallopian tubes and ovaries. Scar tissue can physically block the path between egg and uterus. Even in early-stage disease where the anatomy looks relatively normal, the inflammatory environment inside the pelvis appears to reduce fertility. Many women with endometriosis do conceive, sometimes naturally and sometimes with assisted reproduction, but the condition meaningfully lowers the odds.
When It Invades Other Organs
In its more aggressive form, called deeply infiltrating endometriosis, the tissue doesn’t just sit on the surface of organs. It grows into them. The bowel and bladder are the most common targets, though other structures in the pelvis can be affected too.
Bowel endometriosis, most often involving the lowest portions of the large intestine, causes pelvic pain, bloating, constipation, diarrhea, pain with bowel movements, and occasionally bloody stools. In some cases the endometrial tissue fuses the rectum to the vagina, which can cause severe pain during intercourse. Most of the time, surgeons can remove the lesion and repair the bowel wall, but when the tissue has grown through the entire bowel wall or affects a large segment, that portion of the bowel needs to be surgically removed.
Urinary tract involvement is less common, affecting about 1% of patients, but carries a quiet danger. Endometrial tissue can constrict or invade the ureters, the tubes connecting the kidneys to the bladder. Symptoms include frequent urination, blood in the urine, and flank pain. In some cases there are no symptoms at all, yet the ureter slowly closes off, which can cause the kidney on that side to lose function permanently. This is one of the clearest examples of why “how serious is endometriosis” can’t be answered with a single number. Most people never face organ damage, but a small percentage do, and sometimes without warning signs.
Endometriosis Beyond the Pelvis
In rare cases, endometrial tissue reaches the chest cavity, landing on the diaphragm, the lining of the lungs, or the lung tissue itself. This is called thoracic endometriosis syndrome, and it can produce alarming symptoms timed to the menstrual cycle. The most common presentation is catamenial pneumothorax, a collapsed lung that occurs within 72 hours of the start of a period, accounting for about 80% of thoracic cases. Other manifestations include fluid or blood collecting around the lung (14% of cases) and coughing up blood (5%).
Diaphragmatic endometriosis can irritate the nerve that runs along the diaphragm, producing cyclic pain in the shoulder, neck, or upper abdomen, typically on the right side. Because these symptoms don’t seem connected to a gynecological condition, they’re frequently misattributed to other causes. Life-threatening complications like massive bleeding in the lungs are rare, but the condition can be incapacitating when it does occur.
The Cancer Connection
Endometriosis is not cancer, but it does carry an elevated cancer risk that’s worth understanding in context. Women with endometriosis have more than four times the risk of ovarian cancer compared to women without the disease. For those with the more severe subtypes, specifically deep infiltrating endometriosis and ovarian endometriomas (blood-filled cysts on the ovaries), the risk climbs to more than nine times that of women without endometriosis. For a specific category of ovarian cancer called type I, the risk among women with severe endometriosis subtypes was nearly 19 times higher, according to NIH-supported research.
These multipliers sound frightening, but they need context. Ovarian cancer is relatively uncommon to begin with. A ninefold increase of a small baseline risk still produces a small absolute risk. Still, it’s a meaningful reason for women with endometriosis, particularly those with endometriomas or deep disease, to stay current with their gynecological care.
Recurrence After Treatment
Endometriosis is a chronic condition with no cure, and even after surgical removal, it comes back at significant rates. The average two-year recurrence rate across studies is about 19%. By five years, recurrence rates for pain range from roughly 21% to 44%, and clinical recurrence (visible disease on imaging or repeat surgery) reaches about 28%. Women with larger ovarian cysts at the time of their first surgery face higher odds of needing a second operation.
This recurrence pattern is one of the most important things to understand about how serious endometriosis is over a lifetime. It’s rarely a “one surgery and done” situation. Many women cycle through periods of symptom control and flare-ups, adjusting treatments as they go. Hormonal therapies can help suppress the disease between surgeries, but they come with their own trade-offs and aren’t an option for women actively trying to conceive.
The Financial and Daily Life Toll
Beyond the physical symptoms, endometriosis imposes a substantial economic burden. An Australian study estimated the total annual cost at roughly $20,900 per person in international dollars, combining healthcare expenses, lost work productivity, and caregiver costs. The striking finding: 84% of that total came from productivity losses, not medical bills. That means the biggest financial hit isn’t the surgeries or medications. It’s the missed workdays, reduced hours, career limitations, and inability to function at full capacity.
This number captures something that clinical staging misses entirely. A woman with “mild” endometriosis who spends two days every month unable to work due to pain is carrying a serious disease by any practical measure, even if her surgical score is low. The impact on relationships, mental health, career progression, and daily functioning is real and cumulative, compounding over the years between symptom onset and diagnosis, and continuing through the cycles of treatment and recurrence that define the condition for many women.